Glucocorticoid Receptor Expression Predicts Good Outcome in response to Taxane-Free, Anthracycline-Based Therapy in Triple Negative Breast Cancer

Triple negative breast cancer (TNBC) is a poor outcome subset of breast cancers characterised by the lack of expression of ER α, PR, and HER2 amplification. It is a heterogeneous group of cancers which fail to derive benefit from modern, more targeted treatments such as Tamoxifen and Herceptin. Curr...

Descripción completa

Detalles Bibliográficos
Autores principales: Elkashif, Ahmed, Bingham, Victoria, Haddock, Paula, Humphries, Matthew P., McQuaid, Stephen, Mullan, Paul B., McCarthy, Helen O., Buckley, Niamh E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256765/
https://www.ncbi.nlm.nih.gov/pubmed/32565802
http://dx.doi.org/10.1155/2020/3712825

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256765/
https://www.ncbi.nlm.nih.gov/pubmed/32565802
http://dx.doi.org/10.1155/2020/3712825

Ejemplares similares